Inicio › Cáncer del colon y del recto › Ohio › Cincinnati
Ensayos clínicos de Cáncer del colon y del recto en Cincinnati, OH
21 estudios para Cáncer del colon y del recto buscan participantes en centros de Cincinnati y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
ReclutandoFase 3
- Oncology Hematology Care - Blue Ash /ID# 280143, Cincinnati
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- y 3 más
Family Communications After Genetic Testing
ReclutandoSe aceptan voluntarios sanos
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- y 4 más
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
ReclutandoFase 1
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · A 15 mi de distancia
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
ReclutandoFase 2
- Oncology Hematology Care - Eastgate /ID# 271493, Cincinnati
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
ReclutandoFase 3
- Oncology Hematology Care - Eastgate, Cincinnati
- Oncology Hematology Care Clinical Trials, LLC, Fairfield · A 15 mi de distancia
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
ReclutandoFase 2
- Research Site, Cincinnati
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
ReclutandoFase 1/2
- University of Cincinnati Medical Center, Cincinnati
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
ReclutandoFase 3
- University of Cincinnati Cancer Institute, Cincinnati
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
ReclutandoFase 3
- Clinical Study Site, Cincinnati
- Clinical Study Site, Cincinnati
- Clinical Study Site, Edgewood · A 8 mi de distancia
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
ReclutandoFase 1
- University of Cincinnati Cancer Center, Cincinnati
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
ReclutandoFase 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
ReclutandoFase 1
- University of Cincinnati (UC) - Cancer Institute, Cincinnati
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
ReclutandoFase 1
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · A 15 mi de distancia
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Oncology Hematology Care Primary, Cincinnati
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
ReclutandoFase 1/2
- University of Cincinnati Cancer Center, Cincinnati
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
ReclutandoFase 1
- The Christ Hospital, Cincinnati
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
ReclutandoFase 1/2
- Christ Hospital Cancer Center, Cincinnati
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
ReclutandoFase 3Se aceptan voluntarios sanos
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- y 1 más
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
ReclutandoFase 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
ReclutandoEstudio observacional
- TriHealth Cancer Institute, Cincinnati
Más información sobre Cáncer del colon y del recto en MedlinePlus
Ensayos de Cáncer del colon y del recto en otras ciudades
- Houston, TX102 estudios
- New York City, NY77 estudios
- Nashville, TN69 estudios
- Boston, MA63 estudios
- Los Angeles, CA59 estudios
- Arlington, VA52 estudios
- St. Louis, MO50 estudios
- San Antonio, TX46 estudios
- Philadelphia, PA44 estudios
- Grand Rapids, MI40 estudios
- Baldwin Park, CA38 estudios
- Seattle, WA34 estudios
Otros estudios en Cincinnati
- Cáncer de pulmón de células no pequeñas35 estudios
- Cáncer (todos los tipos)27 estudios
- Cáncer de seno25 estudios
- Fallo cardíaco24 estudios
- Leucemia mielógena aguda20 estudios
- Cáncer metastásico20 estudios
- Cáncer de ovario19 estudios
- Cáncer de pulmón19 estudios
- Obesidad19 estudios
- Cáncer de próstata18 estudios
- Mieloma múltiple17 estudios
- Melanoma17 estudios
De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.